Apg Asset Management N.V. Biogen Inc. Transaction History

Apg Asset Management N.V.

$59.3 Billion
Q2 2024

A detailed history of Apg Asset Management N.V. transactions in Biogen Inc. stock. As of the latest transaction made, Apg Asset Management N.V. holds 129,576 shares of BIIB stock, worth $22.5 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

129,576

Previous 126,670 2.29%

Holding current value

$22.5 Million

Previous $27.3 Million 9.98%

% of portfolio

0.05%

Previous 0.04%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$190.52 - $236.72 $553,651 - $687,908	2,906 Added 2.29%	129,576 $30 Million
Q1 2024 May 14, 2024	BUY	$212.02 - $267.71 $728,076 - $919,316	3,434 Added 2.79%	126,670 $27.3 Million
Q4 2023 Feb 13, 2024	BUY	$222.59 - $267.94 $2.46 Million - $2.96 Million	11,038 Added 9.84%	123,236 $31.9 Million
Q3 2023 Nov 14, 2023	SELL	$253.3 - $285.89 $3.56 Million - $4.02 Million	-14,074 Reduced 11.15%	112,198 $28.8 Million
Q2 2023 Aug 14, 2023	SELL	$275.25 - $318.06 $617,936 - $714,044	-2,245 Reduced 1.75%	126,272 $36 Million
Q1 2023 May 12, 2023	SELL	$256.56 - $292.34 $9.39 Million - $10.7 Million	-36,604 Reduced 22.17%	128,517 $35.7 Million
Q4 2022 Feb 14, 2023	BUY	$252.44 - $306.72 $28 Million - $34 Million	110,772 Added 203.82%	165,121 $45.7 Million
Q3 2022 Nov 14, 2022	BUY	$194.69 - $268.46 $1.97 Million - $2.72 Million	10,115 Added 22.87%	54,349 $14.8 Million
Q2 2022 Aug 12, 2022	SELL	$187.54 - $223.02 $1.06 Million - $1.25 Million	-5,627 Reduced 11.29%	44,234 $8.63 Million
Q1 2022 May 12, 2022	BUY	$193.77 - $244.14 $4.26 Million - $5.37 Million	22,000 Added 78.96%	49,861 $9.44 Million
Q4 2021 Feb 11, 2022	BUY	$223.92 - $287.77 $134,352 - $172,662	600 Added 2.2%	27,861 $5.88 Million
Q3 2021 Nov 15, 2021	SELL	$282.99 - $369.05 $10.2 Million - $13.3 Million	-36,000 Reduced 56.91%	27,261 $6.66 Million
Q2 2021 Aug 13, 2021	SELL	$259.0 - $414.71 $7.18 Million - $11.5 Million	-27,734 Reduced 30.48%	63,261 $18.5 Million
Q1 2021 May 14, 2021	SELL	$242.95 - $284.63 $21.2 Million - $24.8 Million	-87,126 Reduced 48.91%	90,995 $21.7 Million
Q4 2020 Feb 12, 2021	SELL	$236.26 - $355.63 $9.94 Million - $15 Million	-42,055 Reduced 19.1%	178,121 $35.6 Million
Q3 2020 Nov 12, 2020	SELL	$264.77 - $305.71 $1.8 Million - $2.08 Million	-6,800 Reduced 3.0%	220,176 $53.3 Million
Q2 2020 Aug 14, 2020	BUY	$258.66 - $342.55 $2.91 Million - $3.85 Million	11,242 Added 5.21%	226,976 $54.1 Million
Q1 2020 May 15, 2020	SELL	$268.85 - $341.04 $138 Million - $176 Million	-514,696 Reduced 70.46%	215,734 $68.3 Million
Q1 2020 May 14, 2020	BUY	$268.85 - $341.04 $120 Million - $152 Million	444,508 Added 155.46%	730,430 $154 Million
Q4 2019 Feb 13, 2020	BUY	$220.06 - $304.07 $3.18 Million - $4.39 Million	14,438 Added 5.32%	285,922 $75.6 Million
Q3 2019 Nov 08, 2019	SELL	$217.44 - $243.88 $65.9 Million - $73.9 Million	-302,846 Reduced 52.73%	271,484 $58 Million
Q2 2019 Aug 13, 2019	SELL	$219.29 - $241.72 $34.2 Million - $37.7 Million	-156,100 Reduced 21.37%	574,330 $118 Million
Q1 2019 May 14, 2019	BUY	$216.71 - $338.96 $303,394 - $474,544	1,400 Added 0.19%	730,430 $154 Million
Q4 2018 Feb 13, 2019	BUY	$278.5 - $352.75 $26 Million - $33 Million	93,500 Added 14.71%	729,030 $192 Million
Q3 2018 Nov 09, 2018	BUY	$293.51 - $383.83 $5.14 Million - $6.72 Million	17,500 Added 2.83%	635,530 $193 Million
Q2 2018 Aug 13, 2018	BUY	$257.52 - $306.91 $15.8 Million - $18.9 Million	61,500 Added 11.05%	618,030 $154 Million
Q1 2018 May 14, 2018	BUY	$260.13 - $367.91 $9.75 Million - $13.8 Million	37,500 Added 7.23%	556,530 $124 Million
Q4 2017 Jan 24, 2018	BUY	$307.64 - $344.58 $13.4 Million - $15 Million	43,603 Added 9.17%	519,030 $138 Million
Q3 2017 Oct 19, 2017	BUY	$281.15 - $329.69 $134 Million - $157 Million	475,427	475,427 $149 Million

Others Institutions Holding BIIB

# of Institutions

1,018

Shares Held

128M

Call Options Held

1.22M

Put Options Held

1.4M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Apg Asset Management N.V., based on Form 13F filings with the SEC.

News

Stay updated on Apg Asset Management N.V. with notifications on news.

Account

Apg Asset Management N.V. Biogen Inc. Transaction History